Stemline Therapeutics Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Stemline Therapeutics (STML) Reports Q2 Loss of $0.66/Share
August 8, 2017 7:25 AM EDTStemline Therapeutics (NASDAQ: STML) reported Q2 EPS of ($0.66), versus ($0.52) reported last year.
For earnings history and earnings-related data on Stemline Therapeutics (STML) click here.
... More